(5-Acetylpyridin-3-yl)boronic acid, 95%, 5g

9-Octyl-3,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole, 97%, 5g

3,5-DIMETHYLI-4-ISOXAZOLECARBOXAMIDE, 98.0%, 250mg

3-Methyl-6-nitrobenzo[d]thiazol-2(3h)-imine, 98%, 5g

Dibenzo[b,e][1,4]dioxine-2,3,7,8-tetraamine tetrahydrochloride, 97%, 250mg

(11bR)-4-mercapto-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepin, 98%, 250mg

(R)-(+)-2-Méthyl-2-propanesulfinamide, min 97 %, 25 g, emballage verre

2-Chloro-3-amino-4-(trifluoromethyl)pyridine, 97.0%, 1g

Methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 5g

2-(2-furyl)ethanamine hydrochloride, 95.0%, 10g

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one, 95.0%, 5g

tert-Butyl 3-(2-(tosyloxy)ethoxy)propanoate, 95%, 100mg

4-(4-Bromopyridin-2-yl)morpholine, 97.0%, 5g